Keyphrases
Epidermal Growth Factor Receptor
100%
Central Nervous System
100%
Retinal Ganglion Cells
100%
AG1478
100%
Off-target Effects
100%
Inhibiting Activity
100%
Axon Growth
100%
Epidermal Growth Factor Receptor Inhibitors
100%
Neurotrophins
83%
Myelin
66%
Neurite Outgrowth
50%
Retinal Ganglion Cell Axons
50%
Cyclic Adenosine Monophosphate (cAMP)
33%
Proteolysis
33%
P75 Neurotrophin Receptor (p75NTR)
33%
Axon Regeneration
33%
Ribonucleic Acid
33%
Nerve Growth Factor
16%
Receptor Activation
16%
Retina
16%
Optic Nerve
16%
Supernatant
16%
Phosphorylation
16%
Optic Nerve Axons
16%
Growth Inhibition
16%
Growth Factor Receptor Tyrosine Kinase
16%
Glia
16%
Calcium-dependent
16%
Beta-blockers
16%
Acid Activation
16%
Novel Therapeutics
16%
Brain-derived Neurotrophic Factor
16%
Acid Treatment
16%
Disinhibition
16%
Kinase Inhibition
16%
Knockdown
16%
Neurite
16%
Epidermal Growth Factor Receptor-tyrosine Kinase Inhibitor (EGFR-TKI)
16%
TrkA
16%
Local Administration
16%
Lesion Site
16%
Glial Inhibitor
16%
Neurotrophin-3 (NT-3)
16%
Optic Nerve Injury
16%
Neuritogenesis
16%
Injury Model
16%
Phosphorylated Epidermal Growth Factor Receptor
16%
Primary Retinal Cultures
16%
K252a
16%
Inhibitory Ligands
16%
Intra-axonal
16%
Optic Nerve Lesion
16%
Neuritogenic Activity
16%
Fc-fusion Protein
16%
Retinal Astrocytes
16%
Neuroscience
Epidermal Growth Factor Receptor
100%
Receptor Antagonist
100%
Neurite Outgrowth
100%
Retinal Ganglion Cell
100%
Central Nervous System
54%
Neurotrophin
45%
Optic Nerve
36%
Myelin
36%
Cyclic Adenosine Monophosphate
18%
Proteolysis
18%
RNA
18%
Nerve Fiber Regeneration
18%
Kinase
9%
Nerve Growth Factor
9%
Astrocyte
9%
Axon
9%
Glia
9%
Brain-Derived Neurotrophic Factor
9%
Disinhibition
9%
Neurite
9%
Fusion Protein
9%
Neuritogenesis
9%
Neurotrophin-3
9%
K252a
9%
Growth Factor Receptor Inhibitor
9%